Anika Therapeutics, Inc. — Director's Dealing 2021

Jun 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anika Therapeutics, Inc. (ANIK)
CIK: 0000898437
Period of Report: 2021-06-16

Reporting Person: Thompson Jeffery S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-16	Common Stock	A	4172	—	Acquired	15121	Direct

Footnotes

F1: These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on the earlier of the 2022 annual meeting of the Company's stockholders or June 16, 2022.